DrugsControl Media Services
DrugsControl.org

News Detail

US FDA approves new antibiotic for hospital-acquired pneumonia (26-05-2023)

Maryland, 25 May 2023: On Tuesday, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by suscepti......
View Details

Source : US FDA NEWS RELEASE
Entasis FDA US FDA hospital-acquired infections (HAI) ventilator AstraZeneca ZAI Lab GSK antimicrobial Pharma

Related News